Advertisement

Topics

Celera Genomics Rockville Company Profile

18:21 EDT 21st September 2018 | BioPortfolio

Celera is a molecular diagnostics business with powerful discovery platforms dedicated to the practice of Targeted Medicine. Located in Rockville, MD and Alameda, CA, the company employs about 300 people and has the full capability to discover, develop, manufacture and secure registration for In Vitro Diagnostic products. To identify novel diagnostic markers and potential drug targets, we are leveraging capabilities in proteomics, genomics and bioinformatics to better understand the association between common diseases (cardiovascular, autoimmune and cancer) and patterns of genetic variation and protein expression. Our strategy is to be a leader in Targeted Medicine by producing new genetic and proteomic-based diagnostics tests that improve patient outcome by predicting disease risk, selecting the most effective therapy and monitoring treatment. Another goal is to capitalize on the value of our discoveries through partnerships to develop new therapies, identify new disease indications for existing drugs, and to provide pharmacogenomic and companion diagnostic tests.Celera has a strategic alliance with Abbott Laboratories through which the companies sell and support molecular diagnostic products. Celera's discovery platforms are the basis for multiple discovery and therapeutic product development collaborations.

Location

45 West Gude Drive
Rockville
Maryland
20850
United States of America

Contact

Phone: (240) 453-3000
Email: investorinfo@celera.com


News Articles [382 Associated News Articles listed on BioPortfolio]

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

Human Genome Sciences Opens Manufacturing and Process Development Plant

Last month, Human Genome Sciences Inc. (HGS; Rockville, MD) opened a new 80,000 square foot, $42 million manufacturing and process development plant, believed to be the first facility in the world des...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

Verge joins Genomics England’s Discovery Forum industry partnership

Genomics England and Verge Genomics, a leading artificial intelligence therapeutics company, announced today that Verge will join Genomics England’s Discovery Forum industry partnership. The partner...

#jobs #lifescience CK Group: Genomics Manufacturing Technician – Hertfordshire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Genomics Manufacturing Technician – Hertfordshire . £18,000:...

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Levels of Bisphenol A in Urine and Saliva Following Placement of Composite Restorations

This study will determine whether placement of composite (white) dental restorations (fillings) increases concentrations of bisphenol A (BPA) and its metabolites in saliva and urine. These...

Companies [464 Associated Companies listed on BioPortfolio]

PE Corporation-Celera Genomics

The Celera Genomics Group is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborat...

Celera Genomics

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera ...

Celera Genomics Rockville

Celera is a molecular diagnostics business with powerful discovery platforms dedicated to the practice of Targeted Medicine. Located in Rockville, MD and Alameda, CA, the company employs about 300 peo...

Celera Corporation

Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary ...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Celera Genomics Rockville" on BioPortfolio

We have published hundreds of Celera Genomics Rockville news stories on BioPortfolio along with dozens of Celera Genomics Rockville Clinical Trials and PubMed Articles about Celera Genomics Rockville for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celera Genomics Rockville Companies in our database. You can also find out about relevant Celera Genomics Rockville Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record